The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin*
Bettina A. Hamelin, Marc Lebel(Université Laval), François Vallée(Université Laval), Jacques Turgeon(Académie Nationale de Médecine), Pierre-Maxime Bélanger(Université Laval), F. Paquet(Université Laval)
Cited by 112
Related Papers
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
|Pharmaceutics|2020|237
Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
|Annals of Pharmacotherapy|2013|186
Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.
|PubMed|1999|177